Exam 5 - Lec 70 Bipolar Ott Flashcards
_______ is the mood pole that is experienced most often in bipolar disorder - can lead to misdiagnoses
depression
alcohol and substance abuse is common (___-___%) in bipolar disorder
50-60%
T or F: Anxiety disorders are common comorbidities and can significantly impact remission of mood episodes if left untreated or inadequately treated
T
bipolar I disorders requires at least ___ manic episdoes
1
bipolar II disorder includes major depressive and __________ episodes
hypomanic
T or F: lithium is associated with an increase in suicidality
F (dec)
T or F: lithium is a narrow therapeutic index (NTI) medication
T
what is the conversion for lithium liquid vs tablets/capsules?
1:1 conversion
acute lithium tx
a. 0.9-1.2 mEq/L
b. 0.6-0.9 mEq/L
c. 1.5 - > 3.0 mEq/L
a. 0.9-1.2 mEq/L
maintenance lithium tx
a. 0.9-1.2 mEq/L
b. 0.6-0.9 mEq/L
c. 1.5 - > 3.0 mEq/L
b. 0.6-0.9 mEq/L
lithium toxicity (mild to severe)
a. 0.9-1.2 mEq/L
b. 0.6-0.9 mEq/L
c. 1.5 - > 3.0 mEq/L
c. 1.5 - > 3.0 mEq/L
we should draw trough serum lithium conc ___ hours after dose initiation, ___ hours after last dose
72; 12
look at slide 12 for lithium toxicities and SE
you got it
T or F: lithium is preferred in 1st trimester of pregnancy
F (avoid in 1st trimester - use with caution in 2nd and 3rd trimester)
what cardiac structure abnormality can lithium cause?
Ebstein’s anomaly
look at slide 13 for lithium lab monitoring
ok
lithium drug interactions: ACEi, ARBs, thiazides, NSAIDs, dehydration
a. dec Li renal clearance
b. inc Li renal clearance
c. inc Li excretion
a. dec Li renal clearance
lithium drug interactions: caffeine, osmotic diuretics, +/- loop diuretics
a. dec Li renal clearance
b. inc Li renal clearance
c. inc Li excretion
b. inc Li renal clearance
lithium drug interactions: sodium bicarb, high Na intake
a. dec Li renal clearance
b. inc Li renal clearance
c. inc Li excretion
c. inc Li excretion
lithium toxicity related to Na depletion is due to which diuretics?
a. thiazides
b. loops
c. osmotic
a. thiazides
ER valproate is ~___-___% less bioavailable than delayed release (DR) dosage form
10-15%
T or F: valproic acid syrup (IR) and capsule sprinkle form has higher risk for GI ulcerations (usually esophageal)
T
conversion for ER valproate and DR valproate
1:1; expect lower serum conc with the ER form - usually not clinically signif
valproate serum levels _____-_____ mcg/mL is associated with the most efficacy in mania
80-125